The Asia Pacific Cosmetic Implants Market should witness market growth of 8.6% CAGR during the forecast period (2022-2028).
Surgeons all around the region frequently carry out these treatments for hand surgery, breast reconstruction, scar revision, tumor removal, and laceration healing. The advent of hyaluronic acid facial filler and two form-stable silicone gel breast implants, among other technological developments, are improving the market picture.
The face, injectable implants orsoft tissue, hair transplants or implantable devices, the chest, a penile implant, the buttocks, or the calf are all cosmetic enhancements. Silicone and porous polyethylene expanded polytetrafluoroethylene are the key ingredients of several aesthetic implants.Some implants give medication, monitor body functions, or support organs and tissues. Some implants are made from human tissue like skin, bone, and other organs. Cosmetic implants enhance a person's look and treat defects caused by genetic disorders, injuries, and accidents. Patients could restore injured body parts more easily due to cosmetic implants. Patients can more quickly recover from an event or improve their looks.
Since China and India are two of the world's most populated nations, the number of older adults in the area is on the rise. India, the second-most populous country in the world, has experienced a dramatic demographic transition over the past 50 years, with the old population nearly doubling, according to the National Library of Medicine. Various variables make it probable that this trend will continue in the upcoming years.
The group also estimated that by 2025, there would be 158.7 million older adults in India and that by 2050, they would outnumber children under 14. The prevalence of wrinkles, fine lines, and other aging signs is predicted to increase considerably in the area with an increase in the older population. The region's desire for anti-aging therapies has grown as a result of the large number of older people living there. Thus, cosmetic implants would become quite popular in the region, boosting the market growth inAPAC.
The China market dominated the Asia Pacific Cosmetic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,200.1 Million by 2028. The Japan market is registering a CAGR of 7.9% during (2022-2028). Additionally, The India market would generate a CAGR of 9.2% during (2022-2028).
Based on Product, the market is segmented into Dental Implants, Facial Implants, Breast Implants and Others. Based on Raw Material, the market is segmented into Metals, Polymers, Ceramics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, AbbVie, Inc., Danaher Corporation, Dentsply Sirona, Inc., Institut Straumann AG, Sientra, Inc., Zimmer Biomet Holdings, Inc., GC Aesthetics PLC, and Polytech Health & Aesthetics GmbH.
Surgeons all around the region frequently carry out these treatments for hand surgery, breast reconstruction, scar revision, tumor removal, and laceration healing. The advent of hyaluronic acid facial filler and two form-stable silicone gel breast implants, among other technological developments, are improving the market picture.
The face, injectable implants orsoft tissue, hair transplants or implantable devices, the chest, a penile implant, the buttocks, or the calf are all cosmetic enhancements. Silicone and porous polyethylene expanded polytetrafluoroethylene are the key ingredients of several aesthetic implants.Some implants give medication, monitor body functions, or support organs and tissues. Some implants are made from human tissue like skin, bone, and other organs. Cosmetic implants enhance a person's look and treat defects caused by genetic disorders, injuries, and accidents. Patients could restore injured body parts more easily due to cosmetic implants. Patients can more quickly recover from an event or improve their looks.
Since China and India are two of the world's most populated nations, the number of older adults in the area is on the rise. India, the second-most populous country in the world, has experienced a dramatic demographic transition over the past 50 years, with the old population nearly doubling, according to the National Library of Medicine. Various variables make it probable that this trend will continue in the upcoming years.
The group also estimated that by 2025, there would be 158.7 million older adults in India and that by 2050, they would outnumber children under 14. The prevalence of wrinkles, fine lines, and other aging signs is predicted to increase considerably in the area with an increase in the older population. The region's desire for anti-aging therapies has grown as a result of the large number of older people living there. Thus, cosmetic implants would become quite popular in the region, boosting the market growth inAPAC.
The China market dominated the Asia Pacific Cosmetic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,200.1 Million by 2028. The Japan market is registering a CAGR of 7.9% during (2022-2028). Additionally, The India market would generate a CAGR of 9.2% during (2022-2028).
Based on Product, the market is segmented into Dental Implants, Facial Implants, Breast Implants and Others. Based on Raw Material, the market is segmented into Metals, Polymers, Ceramics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, AbbVie, Inc., Danaher Corporation, Dentsply Sirona, Inc., Institut Straumann AG, Sientra, Inc., Zimmer Biomet Holdings, Inc., GC Aesthetics PLC, and Polytech Health & Aesthetics GmbH.
Scope of the Study
By Product
- Dental Implants
- Facial Implants
- Breast Implants
- Others
By Raw Material
- Metals
- Polymers
- Ceramics
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- 3M Company
- AbbVie, Inc.
- Danaher Corporation
- Dentsply Sirona, Inc.
- Institut Straumann AG
- Sientra, Inc.
- Zimmer Biomet Holdings, Inc.
- GC Aesthetics PLC
- Polytech Health & Aesthetics GmbH
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cosmetic Implants Market, by Product
1.4.2 Asia Pacific Cosmetic Implants Market, by Raw Material
1.4.3 Asia Pacific Cosmetic Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Cosmetic Implants Market
Chapter 4. Asia Pacific Cosmetic Implants Market by Product
4.1 Asia Pacific Dental Implants Market by Country
4.2 Asia Pacific Facial Implants Market by Country
4.3 Asia Pacific Breast Implants Market by Country
4.4 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Cosmetic Implants Market by Raw Material
5.1 Asia Pacific Metals Market by Country
5.2 Asia Pacific Polymers Market by Country
5.3 Asia Pacific Ceramics Market by Country
5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Cosmetic Implants Market by Country
6.1 China Cosmetic Implants Market
6.1.1 China Cosmetic Implants Market by Product
6.1.2 China Cosmetic Implants Market by Raw Material
6.2 Japan Cosmetic Implants Market
6.2.1 Japan Cosmetic Implants Market by Product
6.2.2 Japan Cosmetic Implants Market by Raw Material
6.3 India Cosmetic Implants Market
6.3.1 India Cosmetic Implants Market by Product
6.3.2 India Cosmetic Implants Market by Raw Material
6.4 South Korea Cosmetic Implants Market
6.4.1 South Korea Cosmetic Implants Market by Product
6.4.2 South Korea Cosmetic Implants Market by Raw Material
6.5 Singapore Cosmetic Implants Market
6.5.1 Singapore Cosmetic Implants Market by Product
6.5.2 Singapore Cosmetic Implants Market by Raw Material
6.6 Malaysia Cosmetic Implants Market
6.6.1 Malaysia Cosmetic Implants Market by Product
6.6.2 Malaysia Cosmetic Implants Market by Raw Material
6.7 Rest of Asia Pacific Cosmetic Implants Market
6.7.1 Rest of Asia Pacific Cosmetic Implants Market by Product
6.7.2 Rest of Asia Pacific Cosmetic Implants Market by Raw Material
Chapter 7. Company Profiles
7.1 3M Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 AbbVie, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 Danaher Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Dentsply Sirona, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Institut Straumann AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Sientra, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.6.5.2 Trials and Approvals:
7.7 Zimmer Biomet Holdings, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.8 GC Aesthetics PLC
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Product Launches and Product Expansions:
7.9 Polytech Health & Aesthetics GmbH
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
Companies Mentioned
- 3M Company
- AbbVie, Inc.
- Danaher Corporation
- Dentsply Sirona, Inc.
- Institut Straumann AG
- Sientra, Inc.
- Zimmer Biomet Holdings, Inc.
- GC Aesthetics PLC
- Polytech Health & Aesthetics GmbH
Methodology
LOADING...
